Xconomy National

Archives

by in

Entry	Author	Date	Location
Why Biogen Idec Got Out of the Corporate VC Business	Luke Timmerman	01/27/12	Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event	Arlene Weintraub	01/26/12	Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More	Bruce V. Bigelow	01/06/12	San Diego
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers	Erin Kutz	01/06/12	Boston
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment	Luke Timmerman	01/04/12	San Diego
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011	Gregory T. Huang	12/28/11	Boston
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles	Luke Timmerman	12/23/11	Seattle
Momenta, Baxter Team Up on Biosimilars	Erin Kutz	12/23/11	Boston
Boston’s Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers	Amy Speak	12/23/11	Boston
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers	Erin Kutz	12/09/11	Boston
The Genetics Institute Impact: Agenda for Xconomy’s Big Event Dec. 14	Luke Timmerman	12/08/11	Boston
Biogen Idec Boosts Biogenerics Strategy With $300M Samsung Joint Venture	Arlene Weintraub	12/06/11	Boston
Seattle Genetics Sees Case of PML, Causing Market Twitch	Luke Timmerman	12/01/11	Seattle
Today’s Xconomy Report: Biogen Idec Meets Goals in Clinical Trial, iRobot Layoffs, $1M Awarded by MassChallenge, and Bay State Venture Capital Earnings	Lilly O'Flaherty	10/28/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter	Gregory T. Huang	10/28/11	Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News	Erin Kutz	10/28/11	Boston
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs	Luke Timmerman	10/27/11	San Francisco
Biogen Idec’s Oral Multiple Sclerosis Drug Passes 2nd Major Test; Stock Soars	Luke Timmerman	10/26/11	Boston
Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” on Dec. 14	Luke Timmerman	10/21/11	Boston
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead	Luke Timmerman	09/06/11	National
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News	Erin Kutz	09/02/11	Boston
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec	Luke Timmerman	08/31/11	Boston
Verizon Buys CloudSwitch, Adimab Inks Biogen and Novo Nordisk Deals, EMD Millpore Buys Amnis, & More Boston-Area Deals News	Erin Kutz	08/31/11	Boston
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk	Erin Kutz	08/29/11	Boston
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies	Luke Timmerman	08/29/11	Seattle
Verizon’s Software Beachhead in Boston: The Story Behind CloudSwitch and Terremark	Gregory T. Huang	08/26/11	Boston
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News	Erin Kutz	07/22/11	Boston
Biogen Idec Moving HQ Back to Cambridge, Constructing Two New Buildings at Kendall Square	Luke Timmerman	07/20/11	Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent	Luke Timmerman	07/18/11	National
Page 1 of 14	next page »